Table 2.

Effect of nanocarrier drug compare to free drug on bacterial susceptibility (mean count ± SD) in broth dilution method.

Name	Bacterial count (CFU/ml) at 0 h	Bacterial count (CFU/ml) at 6 h	Bacterial count (CFU/ml) at 12 h
C1	3.67 ± 0.47 × 106	2.33 ± 0.47 × 104	2.5 ± 0.82 × 105
C2	3.67 ± 0.47 × 106	TFTC	TFTC
C3	3.67 ± 0.47 × 106	TFTC	TFTC
C4	3.67 ± 0.47 × 106	TFTC	TFTC
D1	3.67 ± 0.47 × 106	1.67 ± 0.47 × 106	1.90 ± 0.82 × 106
D2	3.67 ± 0.47 × 106	1.17 ± 0.12 × 106	2.4 ± 0.82 × 106
D3	3.67 ± 0.47 × 106	5.50 ± 0.50 × 105	7.50 ± 0.50 × 105
D4	3.67 ± 0.47 × 106	TFTC	TFTC
Nanocarrier	3.67 ± 0.47 × 106	6.67 ± 0.94 × 105	3.67 ± 0.47 × 105
Control	3.67 ± 0.47 × 106	TNTC	TNTC

TNTC too numerous to count, TFTC too few to count, C₁, C₂, C₃, C₄ nano carrier with 1, 5, 10, and 20 µg/ml CFX respectively, D₁, D₂, D₃, D₄ 1, 5, 10, and 20 µg/ml CFX, respectively.